Get started
AARTI DRUGS LTD.AARTI DRUGS LTD.AARTI DRUGS LTD.

AARTI DRUGS LTD.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

AARTIDRUGS trade ideas

Aarti Drugs Dares To Move Up. X/2 Entry in Aarti Drugs can be taken after closing above 467 and second X/2 entry can be taken after closing above 475. Targets will be 489 and 510. Long term target in the company will be 531. Stop loss in the company can be maintained at a closing below 440. Aarti Drugs Ltd. is a manufacturer of APIs Pharma intermediates and specialty chemicals. Negative of Aarti Drugs are that they have declining net profits. Positives are such that they have Zero Promoter Pledge, Increasing Net Profit, FIIs are increasing stake and have Improving Cash Flow.
NSE:AARTIDRUGSLong
by Happy_Candles_Investment
Aarti Drugs Target 485-520Market Expectation At ₹432.55, the market expects Aarti Drugs to grow profits by 12.4% per year If it grows profits by 15.4% per year, the stock should be priced at ₹488.23. current share price is 11% Undervalued Past Performance Last year, profits declined by -21.6% Profits over past 5 years grew by 26.3% per year Forecast Range from 3 Analysts To achieve the most bearish analyst forecast (₹460.00), profits would need to grow by 13.9% per year To achieve the most bullish analyst forecast (₹485.00), profits would need to grow by 15.2% per year Industry & Market Trend Companies in the Pharmaceuticals industry grew profits by 4.4% last year Companies in the India market grew profits by 30.8% last year Company has delivered good profit growth of 21.37% CAGR over last 5 years Company has a good return on equity (ROE) track record: 3 Years ROE 26.13% Good Risk to Reward Show
NSE:AARTIDRUGSLong
by TechieindusTrader